Skip to content

Evaluation of Irritancy/Allergic Sensitivity to Natural Personal-care Products by Patch Tests

Dermatologically Tested - Patch Tests - to Assess the Irritancy/Allergic Sensitivity of the Natural Personal-care Products Developed by Mother's Choice.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01816542
Enrollment
100
Registered
2013-03-22
Start date
2013-06-30
Completion date
2013-09-30
Last updated
2013-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergy, Cosmetic Allergy, Cutaneous Patch, Dermatitis, Eczema; Contact, Allergic

Keywords

patch-testing, personal-care, cosmetic, dermatitis, allergy, sensitive skin

Brief summary

The purpose of the study is to determine if any of Mother's Choice' all-natural personal-care products cause either irritation or allergic reaction when applied to both normal or sensitive skin. Each product will be tested on the skin using patch tests.

Detailed description

Volunteers will be seen on Day #0 and the study purpose will be explained. Each volunteer will be interviewed to determine if he/she has any exclusion criteria. If there is no contraindication, and agreement is achieved,consent forms will be signed. Volunteers will be examined by a lactic acid test to determine if he/she has normal or sensitive skin. In this test, a Finn's cell (plastic cell, size 1\*1 cm) with lactic acid (50 microliter, 10%w/v) will be placed on the volunteer's cheek for ten minutes. The volunteer will be defined as sensitive or normal according to the degree of discomfort they report. Patch-tests will be performed in the standard method. The materials to be tested will be placed in Finn's cells and attached to the participants healthy skin's back by a plaster (Micropore).The chambers will be left on the skin for 48 hours. The test will be read by a specialist one hour after chambers' removal and 48 hours afterwards. Any erythema,edema, blisters, pustules or erosions on the skin in the patch area will be considered a positive response, and will be evaluated by clinical tools as being of the irritant or the allergic type. in case of uncertainty we may use a confocal microscope for in vivo diagnosis. Ingredients: appropriate concentrations and solvents of the test materials will be prepared according to accepted standards (refer to: Anton C. De Groot: Patch Testing, 3ed Edition, Wapserveen, The Netherlands, 2009).Leave on products will be tested 'as is'. Rinse off products will be diluted to 5% and 0.5%. If the skin stays normal after the patch removal, it means that contact with the material did not cause allergy or irritation.

Interventions

OTHERpatch tests on healthy skin

Patches will be placed on healthy skin.

Sponsors

Mother's Choice Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

\- Healthy adults

Exclusion criteria

* Pregnant subjects * Subjects with an allergy or a skin disease which interferes with the proper results of the tests. * Subjects who are taking medications which can interfere with the proper results of the tests. For example: systemic corticosteroids, topical steroids applied to the test area. * Subjects with sun or phototherapy induced tanning at the test area. * Subject who had been participating in allergy tests within eight weeks prior to the present tests.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with positive reactions, number of positive reactions.One weekErythema, edema, blisters, pustules or erosions on the skin in the patch area will be considered a positive response. If the skin is normal after the patch removal, it means that contact with the material do not cause allergy or irritation.

Secondary

MeasureTime frameDescription
Number of irritant versus allergic reactions, as determined by confocal microscopy.On the spotIn case of a positive reaction, it will be examined by confocal microscopy, by a specialist, to determine whether the reaction is irritant or allergic in nature.

Countries

Israel

Contacts

Primary ContactTova Silberstein, Dr.
clinical.mc.2013@gmail.com972-25610752
Backup ContactLiran Horev, MD
972-26776366

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026